Overview

Evaluation of [18F]MNI-815 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Tauopathies

Status:
Completed
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
The overall goal of this imaging trial is to characterize [18F]MNI-815, a PET radioligand for imaging Tau.
Phase:
Early Phase 1
Details
Lead Sponsor:
Molecular NeuroImaging
Collaborators:
Life Molecular Imaging SA
Piramal Imaging SA